Key result
ETA blockade improves hemodynamics in experimental CHF, whereas ETB blockade causes adverse effects.
Why the study?
The roles of endogenous endothelin via ETA and ETB receptors in hemodynamic, hormonal, and body fluid regulation in congestive heart failure were not fully understood, nor were the therapeutic effects of selective ETA and ETB receptor antagonists.
Do selective ETA and ETB receptor antagonists have differential effects on cardiorenal and neurohormonal variables in a canine model of congestive heart failure?
Do selective ETA and ETB receptor antagonists have differential effects on cardiorenal and neurohormonal variables in a canine model of congestive heart failure?
Answers are grounded in this paper and cite their sources.
In a canine model of heart failure, selective ETA receptor antagonism improved hemodynamics and diuresis, whereas ETB receptor antagonism worsened hemodynamics, suggesting ETA receptors mediate the detrimental effects of endogenous endothelin.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wada et al. (1997) studied Congestive heart failure (n=16). ETA receptor antagonist FR139317 and ETB receptor antagonist RES-701-1 was evaluated on Cardiorenal and hormonal functions. In dogs with CHF, the ETA receptor antagonist FR139317 decreased cardiac pressures and increased cardiac output, whereas the ETB receptor antagonist RES-701-1 had adverse hemodynamic effects.
Synapse has enriched 10 related papers. Consider them for comparative context: